Dioxamycin is a benz[a] anthraquinone antibiotic and kinase inhibitor with the molecular formula C38H40O15.[1][2][3] Dioxamycin is produced by the bacterium Streptomyces cocklensis and Streptomyces xantholiticus.[2][4]
Names | |
---|---|
IUPAC name
(2S,4S,5S)-4-[(1E,3E,5E)-7-[(2R,6R)-6-[(2R,3S,4aR,12bS)-2,3,4a,8,12b-pentahydroxy-3-methyl-1,7,12-trioxo-2,4-dihydrobenzo[a]anthracen-9-yl]-2-methyloxan-3-yl]oxy-7-oxohepta-1,3,5-trienyl]-2,5-dimethyl-1,3-dioxolane-2-carboxylic acid[1]
| |
Identifiers | |
3D model (JSmol)
|
|
ChemSpider | |
PubChem CID
|
|
| |
| |
Properties | |
C38H40O15 | |
Molar mass | 736.723 g·mol−1 |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
|
References
edit- ^ a b "Dioxamycin". Pubchem.ncbi.NLM.nih.gov.
- ^ a b Rahman, Atta-ur (20 January 2015). Studies in Natural Products Chemistry. Elsevier. p. 422. ISBN 978-0-444-63470-2.
- ^ Sawa, Ryuichi; Matsuda, Naoko; Uchida, Takeshi; Ikeda, Takako; Sawa, Tsutomu; Naganawa, Hiroshi; Hamada, Masa; Takeuchi, Tomio (1991). "Dioxamycin, a new benz(a)anthraquinone antibiotic". The Journal of Antibiotics. 44 (4): 396–402. doi:10.7164/antibiotics.44.396. PMID 2032948.
- ^ Kim, Byung-Yong; Zucchi, Tiago Domingues; Fiedler, Hans-Peter; Goodfellow, Michael (1 February 2012). "Streptomyces cocklensis sp. nov., a dioxamycin-producing actinomycete". International Journal of Systematic and Evolutionary Microbiology. 62 (2): 279–283. doi:10.1099/ijs.0.029983-0. PMID 21398501.
Further reading
edit- Thomson, R. H. (6 December 2012). Naturally Occurring Quinones IV: Recent advances. Springer Science & Business Media. p. 544. ISBN 978-94-009-1551-0.